{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:39:09Z","timestamp":1792669149830,"version":"4.5.0"},"reference-count":43,"publisher":"MyJove Corporation","issue":"137","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/57934","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T20:00:07Z","timestamp":1530734407000},"source":"Crossref","is-referenced-by-count":1,"title":["Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice"],"prefix":"10.3791","author":[{"given":"Mathilde","family":"Beka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha","family":"Leal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"issue":"25","key":"ref1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJM198112173052502","type":"journal-article","article-title":"Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis","volume":"305","author":"Knowles","year":"1981","unstructured":"Knowles, M., Gatzy, J., Boucher, R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.New England Journal of Medicine. 305 (25), 1489-1495 (1981).","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1183\/09031936.94.07112050","type":"journal-article","article-title":"Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium","volume":"7","author":"Middleton","year":"1994","unstructured":"Middleton, P.G., Geddes, D.M., Alton, E.F.W. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. European Respiratory Journal. 7 (11), 2050-2056 (1994).","journal-title":"European Respiratory Journal"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/hum.1995.6.4-445","type":"journal-article","article-title":"In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis","volume":"6","author":"Knowles","year":"1995","unstructured":"Knowles, M.R., Paradiso, A.M., Boucher, R.C.In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Human Gene Therapy. 6, (4), 445-455 (1995).","journal-title":"Human Gene Therapy"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-008-8083-0","type":"journal-article","article-title":"Atypical cystic fibrosis and CFTR-related disorders","volume":"35","author":"Paranjape","year":"2008","unstructured":"Paranjape, S.M., Zeitlin, P.L. Atypical cystic fibrosis and CFTR-related disorders. Clinical Reviews in Allergy & Immunology. 35 (3), 116-123 (2008).","journal-title":"Clinical Reviews in Allergy & Immunology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/ajrccm.161.3.9904116","type":"journal-article","article-title":"A pilot study of the effect of gentamicin on nasal potential difference measurements in CF patients carrying stop mutations","volume":"161","author":"Wilschanski","year":"2000","unstructured":"Wilschanski, M. et al. A pilot study of the effect of gentamicin on nasal potential difference measurements in CF patients carrying stop mutations.American Journal of Respiratory and Critical Care Medicine. 161 (3 Pt 1), 860-865 (2000).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","type":"journal-article","article-title":"Evidence that systemic gentamicin suppresses premature stop mutations in patients with CF","volume":"163","author":"Clancy","year":"2001","unstructured":"Clancy, J.P. et al. Evidence that systemic gentamicin suppresses premature stop mutations in patients with CF. American Journal of Respiratory and Critical Care Medicine. 163 (7), 1683-1692 (2001).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","type":"journal-article","article-title":"Gentamicin-induced correction of CFTR function in patients with CF and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","unstructured":"Wilschanski, M. et al. Gentamicin-induced correction of CFTR function in patients with CF and CFTR stop mutations. New England Journal of Medicine. 349 (15), 1433-1441 (2003).","journal-title":"New England Journal of Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","type":"journal-article","article-title":"In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with CF: a pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","unstructured":"Sermet-Gaudelus, I. et al. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with CF: a pilot study. BMC Medicine. 5, 5 (2007).","journal-title":"BMC Medicine"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2006-0173OC","type":"journal-article","article-title":"No detectable improvements in CF transmembrane conductance regulator by nasal aminoglycosides in patients with CF with stop mutations","volume":"37","author":"Clancy","year":"2007","unstructured":"Clancy, J.P. et al. No detectable improvements in CF transmembrane conductance regulator by nasal aminoglycosides in patients with CF with stop mutations. American Journal of Respiratory and Cell Molecular Biology. 37 (1), 57-66 (2007).","journal-title":"American Journal of Respiratory and Cell Molecular Biology"},{"issue":"9640","key":"ref10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","type":"journal-article","article-title":"Effectiveness of PTC124 treatment of CF caused by nonsensemutations: a prospective phase II trial","volume":"372","author":"Kerem","year":"2008","unstructured":"Kerem, E. et al. Effectiveness of PTC124 treatment of CF caused by nonsensemutations: a prospective phase II trial. Lancet. 372 (9640), 719-727 (2008).","journal-title":"Lancet"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","type":"journal-article","article-title":"Ataluren (PTC124) induces CF transmembrane conductance regulator protein expression and activity in children with nonsense mutation CF","volume":"182","author":"Sermet-Gaudelus","year":"2010","unstructured":"Sermet-Gaudelus, I. et al. Ataluren (PTC124) induces CF transmembrane conductance regulator protein expression and activity in children with nonsense mutation CF. American Journal of Respiratory and Critical Care Medicine. 182 (10), 1262-1272 (2010).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09031936.00120910","type":"journal-article","article-title":"Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis","volume":"38","author":"Wilschanski","year":"2011","unstructured":"Wilschanski, M., et al. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. European Respiratory Journal. 38 (1), 59-69 (2011).","journal-title":"European Respiratory Journal"},{"issue":"21","key":"ref13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","type":"journal-article","article-title":"Effect of VX-770 in persons with CF and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","unstructured":"Accurso, F.J. et al. Effect of VX-770 in persons with CF and the G551D-CFTR mutation. New England Journal of Medicine. 363 (21), 1991-2003 (2010).","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","type":"journal-article","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","unstructured":"Clancy, J.P. et al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 67 (1), 12-18 (2012).","journal-title":"Thorax"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcf.2011.12.004","type":"journal-article","article-title":"A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference","volume":"11","author":"Leonard","year":"2012","unstructured":"Leonard, A., Lebecque, P., Dingemanse, J., Leal, T. A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference. Journal of Cystic Fibrosis. 11 (3), 231-236 (2012).","journal-title":"Journal of Cystic Fibrosis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/09031936.00057512","type":"journal-article","article-title":"CFTR biomarkers: time for promotion to surrogate end-point","volume":"41","author":"De Boeck","year":"2013","unstructured":"De Boeck, K. et al. CFTR biomarkers: time for promotion to surrogate end-point. European Respiratory Journal. 41:203-216 (2013).","journal-title":"European Respiratory Journal"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1258\/002367706775404480","type":"journal-article","article-title":"Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice","volume":"40","author":"Leal","year":"2006","unstructured":"Leal, T. et al.Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice. Laboratory Animals. 40 (1), 43-52 (2006).","journal-title":"Laboratory Animals"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1164\/rccm.200703-344OC","type":"journal-article","article-title":"Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis","volume":"177","author":"Lubamba","year":"2008","unstructured":"Lubamba, B. et al. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 177 (5), 506-515 (2008).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.200901-0049OC","type":"journal-article","article-title":"Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice","volume":"179","author":"Lubamba","year":"2009","unstructured":"Lubamba, B. et al. Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice. American Journal of Respiratory and Critical Care Medicine. 179 (11), 1022-1028 (2009).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09031936.00013510","type":"journal-article","article-title":"Inhaled PDE5 inhibitors restore chloride transport in cystic fibrosis mice","volume":"37","author":"Lubamba","year":"2011","unstructured":"Lubamba, B. et al. Inhaled PDE5 inhibitors restore chloride transport in cystic fibrosis mice. European Respiratory Journal. 37 (1), 72-78 (2011).","journal-title":"European Respiratory Journal"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/rccm.201505-0914OC","type":"journal-article","article-title":"rAAV-CFTR\u0394R Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice","volume":"193","author":"Vidovic","year":"2016","unstructured":"Vidovic, D., et al. rAAV-CFTR\u0394R Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. American Journal of Respiratory and Critical Care Medicine. 193 (3), 288-298 (2016).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5225","key":"ref22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.7543698","type":"journal-article","article-title":"CFTR as a cAMP-dependent regulator of sodium channels","volume":"269","author":"Stutts","year":"1995","unstructured":"Stutts, M.J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science. 269 (5225), 847-850 (1995).","journal-title":"Science"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.clinbiochem.2012.05.034","type":"journal-article","article-title":"Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy","volume":"45","author":"Lubamba","year":"2012","unstructured":"Lubamba, B., Dhooghe, B., Noel, S., Leal, T. Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy. Clinical Biochemistry. 45 (15), 1132-1144 (2012).","journal-title":"Clinical Biochemistry"},{"issue":"4922","key":"ref24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","type":"journal-article","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","unstructured":"Kerem, B. et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 245 (4922), 1073-1080 (1989).","journal-title":"Science"},{"issue":"4925","key":"ref25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","type":"journal-article","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","unstructured":"Riordan, J.R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245 (4925), 1066-1073 (1989).","journal-title":"Science"},{"issue":"22","key":"ref26","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1074\/jbc.272.22.14037","type":"journal-article","article-title":"Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics","volume":"272","author":"Stutts","year":"1997","unstructured":"Stutts, M.J., Rossier, B.C., Boucher, R.C. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. Journal of Biological Chemistry. 272 (22), 14037-14040 (1997).","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1074\/jbc.271.9.4725","type":"journal-article","article-title":"Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator","volume":"271","author":"Ismailov","year":"1996","unstructured":"Ismailov, I.I. et al. Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator. Biological Chemistry. 271 (9), 4725-4732 (1996).","journal-title":"Biological Chemistry"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/18744672112059990025","type":"journal-article","article-title":"ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art","volume":"6","author":"Althaus","year":"2013","unstructured":"Althaus, M. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art. Current Molecular Pharmacology. 6 (1), 3-12 (2013).","journal-title":"Current Molecular Pharmacology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1569-1993(11)60020-9","type":"journal-article","article-title":"Mouse models of cystic fibrosis: phenotypic analysis and research applications","volume":"10","author":"Wilke","year":"2011","unstructured":"Wilke, M. et al. Mouse models of cystic fibrosis: phenotypic analysis and research applications. Journal of Cystic Fibrosis. 10 (Suppl 2), S152-S171 (2011).","journal-title":"Journal of Cystic Fibrosis"},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","type":"journal-article","article-title":"A mouse model for the cystic fibrosis delta F508 mutation","volume":"14","author":"Van Doorninck","year":"1995","unstructured":"Van Doorninck, J.H. et al. A mouse model for the cystic fibrosis delta F508 mutation. The EMBO Journal. 14 (18), 4403-4411 (1995).","journal-title":"The EMBO Journal"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng0895-445","type":"journal-article","article-title":"Generation and characterization of a delta F508 cystic fibrosis mouse model","volume":"10","author":"Colledge","year":"1995","unstructured":"Colledge, W.H. et al. Generation and characterization of a delta F508 cystic fibrosis mouse model. Nature Genetics. 10 (4), 445-452 (1995).","journal-title":"Nature Genetics"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI118253","type":"journal-article","article-title":"A mouse model for the delta F508 allele of cystic fibrosis","volume":"96","author":"Zeiher","year":"1995","unstructured":"Zeiher, B.G. et al. A mouse model for the delta F508 allele of cystic fibrosis. Journal of Clinical Investigation. 96 (4), 2051-2064 (1995).","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/thx.51.12.1229","type":"journal-article","article-title":"Modification of the nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse","volume":"51","author":"Ghosal","year":"1996","unstructured":"Ghosal, S., Taylor, C.J., McGray, J. Modification of the nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse. Thorax. 51 (12), 1229-1232 (1996).","journal-title":"Thorax"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/09031936.00.15114600","type":"journal-article","article-title":"Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice","volume":"15","author":"Ghosal","year":"2000","unstructured":"Ghosal, S., Taylor, C.J., Colledge, W.H., Ratcliff, R., Evans, M.J. Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice. European Respiratory Journal. 15 (1), 146-50 (2000).","journal-title":"European Respiratory Journal"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4236\/ojrd.2012.22007","type":"journal-article","article-title":"Comparative Variability of Nasal Potential Difference Measurements in Human and Mice","volume":"2","author":"Leonard","year":"2012","unstructured":"Leonard, A. et al.Comparative Variability of Nasal Potential Difference Measurements in Human and Mice. Open Journal of Respiratory Disease. 2, 43-56 (2012).","journal-title":"Open Journal of Respiratory Disease"},{"issue":"2","key":"ref36","first-page":"120","type":"journal-article","article-title":"Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose","volume":"54","author":"Tannenbaum","year":"2015","unstructured":"Tannenbaum, J., Bennett, B.T. Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose. Journal of the American Association for Laboratory Animal Science. 54 (2), 120-132 (2015).","journal-title":"Journal of the American Association for Laboratory Animal Science"},{"issue":"6","key":"ref37","first-page":"633","type":"journal-article","article-title":"AALAS\/FELASA Working Group on Health Monitoring of rodents for animal transfer","volume":"53","author":"Pritchett-Corning","year":"2014","unstructured":"Pritchett-Corning, K.R et al. AALAS\/FELASA Working Group on Health Monitoring of rodents for animal transfer. Journal of the American Association for Laboratory Animal Science. 53 (6), 633-640 (2014).","journal-title":"Journal of the American Association for Laboratory Animal Science"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1152\/ajplung.00354.2003","type":"journal-article","article-title":"CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor","volume":"287","author":"Salinas","year":"2004","unstructured":"Salinas, D.B. et al.CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor. American Journal of Physiology. Lung Cell Molecular Physiology. 287 (5), L936-943 (2004).","journal-title":"American Journal of Physiology. Lung Cell Molecular Physiology"},{"issue":"26","key":"ref39","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.M111.336537","type":"journal-article","article-title":"Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator","volume":"287","author":"Fisher","year":"2012","unstructured":"Fisher, J.T. et al. Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator. Journal of Biological Chemistry. 287 (26), 21673-21685 (2012).","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"0186984","DOI":"10.1371\/journal.pone.0186984","type":"journal-article","article-title":"Use of ferrets for electrophysiologic monitoring of ion transport","volume":"12","author":"Kaza","year":"2017","unstructured":"Kaza, N. et al. Use of ferrets for electrophysiologic monitoring of ion transport. PLoS One. 12 (10), e0186984 (2017).","journal-title":"PLoS One"},{"issue":"S1","key":"ref41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1569-1993(17)30400-9","type":"journal-article","article-title":"Nasal potential difference in \u03b2ENaC-overexpressing mouse reveals pH-sensitive channel hyperactivity and shift of subunits stoichiometry","volume":"16","author":"Leal","year":"2017","unstructured":"Leal, T., Beka, M., Panin, N., Mall, M.A., Noel, S. Nasal potential difference in \u03b2ENaC-overexpressing mouse reveals pH-sensitive channel hyperactivity and shift of subunits stoichiometry. Journal of Cystic Fibrosis. 16 (S1), S72 (2017).","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nm1028","type":"journal-article","article-title":"Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice","volume":"10","author":"Mall","year":"2004","unstructured":"Mall, M., Grubb, B.R., Harkema, J.R., O'Neal, W.K., Boucher, R.C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.Nature Medicine. 10 (5), 487-93 (2004).","journal-title":"Nature Medicine"},{"issue":"6272","key":"ref43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aad5589","type":"journal-article","article-title":"Airway acidification initiates host defense abnormalities in cystic fibrosis mice","volume":"351","author":"Shah","year":"2016","unstructured":"Shah, V.S. et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science. 351 (6272), 503-507 (2016).","journal-title":"Science"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/video\/57934\/nasal-potential-difference-to-quantify-trans-epithelial-ion-transport","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:52:33Z","timestamp":1792666353000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/57934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":43,"journal-issue":{"issue":"137","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3791\/57934","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]}}}